{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:48:16Z","timestamp":1762458496859},"reference-count":18,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.radonc.2006.03.014","type":"journal-article","created":{"date-parts":[[2006,5,3]],"date-time":"2006-05-03T13:21:07Z","timestamp":1146662467000},"page":"179-184","source":"Crossref","is-referenced-by-count":32,"title":["Analyses of dose\u2013response in radiotherapy for patients with mature T\/NK-cell lymphomas according to the WHO classification"],"prefix":"10.1016","volume":"79","author":[{"given":"Koh-ichi","family":"Sakata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobukazu","family":"Fuwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kodaira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Aratani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hikaru","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masamichi","family":"Nishio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeo","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetoshi","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Hareyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2006.03.014_bib1","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","article-title":"The non-hodgkin's lymphoma classification project","volume":"89","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.radonc.2006.03.014_bib2","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1182\/blood.V89.12.4514","article-title":"Evaluation of the Revised European-American Lymphoma classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin's lymphoma","volume":"89","author":"Melnyk","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.radonc.2006.03.014_bib3","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1200\/JCO.1989.7.6.725","article-title":"Direct comparisons of peripheral T-cell lymphoma with diffuse B-cell lymphoma of comparable histological grades\u2014should peripheral T-cell lymphoma be considered separately?","volume":"7","author":"Cheng","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2006.03.014_bib4","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3109\/02841869709001268","article-title":"Treatment of lethal midline granuloma type nasal T-cell lymphoma","volume":"36","author":"Sakata","year":"1997","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2006.03.014_bib5","first-page":"76","article-title":"Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA)","volume":"92","author":"Gisselbrecht","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.radonc.2006.03.014_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0167-8140(95)01668-6","article-title":"Experience of radiotherapy in lethal midline granuloma with special emphasis on centrofacial T-cell lymphoma: a retrospective analysis covering a 34-year period","volume":"38","author":"Chen","year":"1996","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2006.03.014_bib7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0167-8140(91)90079-V","article-title":"A radiotherapeutic experience for localized extranodal non-Hodgkin's lymphoma: prognostic factors and re-evaluation of treatment modality","volume":"21","author":"Tsutsui","year":"1991","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2006.03.014_bib8","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000050305","article-title":"Treatment of aggressive, or progressing indolent peripheral T- and NK-cell neoplasias by combination of fludarabine, cyclophosphamide and doxorubicine","volume":"24","author":"Weidmann","year":"2001","journal-title":"Onkologie"},{"key":"10.1016\/j.radonc.2006.03.014_bib9","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European\u2013American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.radonc.2006.03.014_bib10","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","article-title":"World health organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting-airlie house, Virginia, November 1997","volume":"17","author":"Harris","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2006.03.014_bib11","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.ijrobp.2003.12.006","article-title":"Angiocentric T-cell and NK\/T-cell lymphomas: radiotherapeutic viewpoints","volume":"59","author":"Koom","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2006.03.014_bib12","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1023\/A:1008376412784","article-title":"Therapeutic management of primary central nervous system lymphoma: lessons from prospective trials","volume":"11","author":"Ferreri","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2006.03.014_bib13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00277-002-0450-y","article-title":"A single-centre study of treatment outcomes and survival in 120 patients with peripheral T-cell non-Hodgkin's lymphoma","volume":"81","author":"Pellatt","year":"2002","journal-title":"Ann Hematol"},{"key":"10.1016\/j.radonc.2006.03.014_bib14","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00066-005-1330-x","article-title":"Analysis of local control in patients with non-Hodgkin's lymphoma according to the WHO classification","volume":"181","author":"Sakata","year":"2005","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2006.03.014_bib15","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1002\/1097-0142(19951201)76:11<2351::AID-CNCR2820761125>3.0.CO;2-1","article-title":"Frequent expression of p-glycoprotein\/MDR1 by nasal T-cell lymphoma cells","volume":"76","author":"Yamaguchi","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2006.03.014_bib16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0167-8140(01)00428-5","article-title":"Combined chemotherapy and radiation versus radiation alone in the management of localized angiocentric lymphoma of the head and neck","volume":"61","author":"Kim","year":"2001","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2006.03.014_bib17","first-page":"724a","article-title":"Final report of E1484: CHOP vs. CHOP+Radiotherapy (RT) for limited stage diffuse aggressive lymphoma","volume":"98","author":"Horning","year":"2001","journal-title":"Proceedings of ASH"},{"key":"10.1016\/j.radonc.2006.03.014_bib18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJM199807023390104","article-title":"Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma","volume":"339","author":"Miller","year":"1998","journal-title":"N Engl J Med"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814006001137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814006001137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T11:57:27Z","timestamp":1586865447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814006001137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S0167814006001137"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2006.03.014","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}